🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the performance of Xonrid® in the prevention and treatment of G...
Status
Completed
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2017-06-15
Trial ID
NCT03255980
Treatments Being Tested
Building on Bayesian design methodologies from volume optimization studies ...
Status
Recruiting
Location
Nanjing First Hospital
Start Date
2025-06-01
Trial ID
NCT06942689
Treatments Being Tested
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
CTCL is a rare form of lymphoma of the skin. While early stages are usually...
Status
Terminated
Location
Boston Medical Center
Start Date
2012-06
Trial ID
NCT01637090
Treatments Being Tested
The purpose of this study is to evaluate the cutaneous toxicity and treatme...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2016-12-19
Trial ID
NCT02822586
Treatments Being Tested
The goal of this European observational study (Frane, Spain, italy, Spain a...
Status
Completed
Location
Institut du Cancer de Montpellier - Val d'Aurelle
Start Date
2024-11-22
Trial ID
NCT06690489
The purpose of this study is to learn about the safety and the risks of usi...
Status
Completed
Location
Rush University Medical Center
Start Date
2010-10
Trial ID
NCT01368276
Treatments Being Tested
This phase I trial studies the side effects and best dose of ruxolitinib wh...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2019-08-16
Trial ID
NCT03874052
This trial studies the side effects of short-term fasting in patients with ...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2020-08-12
Trial ID
NCT04387084
This phase II trial compares tuvusertib in combination with avelumab to tuv...
Status
Active Not Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2024-05-21
Trial ID
NCT05947500